Related Experiment Video
Updated: Jul 5, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression
1Division of General Medical Sciences-Oncology, Case School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
Abstract:
Survivin is a prosurvival protein overexpressed in many cancers through mechanisms that remain poorly explored, and is implicated in control of tumor progression and resistance to cancer chemotherapeutics. Here, we report a critical role for survivin in the induction of apoptosis by transforming growth factor-beta (TGF-beta). We show that TGF-beta rapidly downregulates survivin expression in prostate epithelial cells, through a unique mechanism of transcriptional suppression involving Smads 2 and 3, Rb/E2F4, and the cell-cycle repressor elements CDE and CHR. This TGF-beta response is triggered through a Smad2/3-dependent hypophosphorylation of Rb and the subsequent association of the Rb/E2F4 repressive complex to CDE/CHR elements in the proximal region of the survivin promoter. Viral-mediated gene delivery experiments, involving overexpressing or silencing survivin, reveal critical roles of survivin in apoptosis induced by TGF-beta alone or in cooperation with cancer therapeutic agents. We propose a novel TGF-beta/Rb/survivin axis with a putative role in the functional switch of TGF-beta from tumor suppressor to tumor promoter.
Insights
Transforming growth factor-beta (TGF-beta) rapidly reduces survivin protein levels in prostate cells. This newly found TGF-beta/Rb/survivin pathway impacts cancer progression and treatment resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- Survivin is a key protein promoting cancer cell survival and drug resistance.
- Mechanisms regulating survivin expression in cancer are not fully understood.
- Transforming growth factor-beta (TGF-beta) plays a complex role in cancer, acting as both a suppressor and promoter.
Purpose of the Study:
- To investigate the role of survivin in TGF-beta-induced apoptosis.
- To elucidate the molecular mechanisms by which TGF-beta regulates survivin expression.
- To explore the potential therapeutic implications of the TGF-beta-survivin interaction.
Main Methods:
- Analysis of survivin expression in prostate epithelial cells.
- Investigating transcriptional regulation involving Smad proteins, Rb/E2F4, and promoter elements (CDE/CHR).
- Utilizing viral-mediated gene delivery for survivin overexpression and silencing.
Main Results:
- TGF-beta rapidly downregulates survivin expression via transcriptional suppression.
- The mechanism involves Smad2/3-dependent Rb hypophosphorylation and Rb/E2F4 complex binding to the survivin promoter.
- Survivin plays a critical role in TGF-beta-induced apoptosis, alone or with chemotherapeutics.
Conclusions:
- A novel TGF-beta/Rb/survivin signaling axis is identified.
- This pathway is crucial for regulating apoptosis in response to TGF-beta.
- The findings suggest a role for this axis in TGF-beta's switch from tumor suppressor to promoter in cancer.
Related Concept Videos
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway

